Asthma
📧 Sign up to get email alerts when something new happens for Asthma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2019-10-07Clinical Trial Update: A Study to Evaluate the Onset of Effect and Time Course of Change in Lung Function With Benralizumab in Severe, Uncontrolled Asthma Patients With Eosinophilic Inflammation [Phase 3]
Phase 3 trial evaluating onset of effect and time course of lung function change with benralizumab in severe eosinophilic asthma; study comp…
-
CLINICAL_TRIALS trial_result · 2019-10-04Clinical Trial Update: p38 Mitogen-Activated Protein Kinase (MAPK) and Steroid Insensitivity in Asthma
Clinical trial update on p38 MAPK pathway and steroid insensitivity in asthma; results have been posted following completion.
-
CLINICAL_TRIALS trial_result · 2019-10-04Clinical Trial Update: Inflammation and Corticosteroid Responsiveness in Severe Asthma
Clinical trial update on inflammation and corticosteroid responsiveness in severe asthma; completed with results posted in 2019.
-
CLINICAL_TRIALS trial_result · 2019-10-04Clinical Trial Update: Safety, Tolerability and Pharmacokinetics of Oral Doses of RP3128 of Rhizen Pharmaceuticals [Phase 1, Phase 2]
Phase 1/2 clinical trial update on oral RP3128 showing safety, tolerability, and pharmacokinetics in healthy volunteers and asthma patients;…
-
CLINICAL_TRIALS safety_alert · 2019-10-02Clinical Trial Update: Post-marketing Safety Monitoring Program of Fluticasone Propionate (FP) in Chinese Subjects With Asthma Aged 1 to <4 Years
Post-marketing safety monitoring study of fluticasone propionate in Chinese children aged 1 to under 4 with asthma has completed and posted …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2019-09-30Clinical Trial Update: Sputum-derived Cellular Targets After Xolair (Omalizumab) [Phase 4]
Phase 4 trial update on sputum-derived cellular targets after omalizumab (Xolair) in asthma; study terminated with results posted.
-
CLINICAL_TRIALS trial_result · 2019-09-27Clinical Trial Update: Immune Dysfunction in Allergic Asthma [NA]
Clinical trial update on immune dysfunction in allergic asthma; study completed with results posted.
-
CLINICAL_TRIALS trial_result · 2019-09-27Clinical Trial Update: Effect of Symbicort on GR Localisation in Asthma [NA]
Clinical trial updating the effect of Symbicort on glucocorticoid receptor localization in asthma; study completed with results posted.
-
CLINICAL_TRIALS trial_result · 2019-09-23Clinical Trial Update: Breathe With Ease: A Unique Approach to Managing Stress (BEAMS) [NA]
Clinical trial BEAMS evaluated a unique approach to managing stress in asthma patients; study completed with results posted in 2019.
-
CLINICAL_TRIALS trial_result · 2019-09-17Clinical Trial Update: Safety and Efficacy of Inhaled Insulin in Patients With Diabetes and Asthma or COPD [Phase 3]
Phase 3 trial update assessing safety and efficacy of inhaled insulin in patients with diabetes and asthma or COPD.
-
CLINICAL_TRIALS trial_result · 2019-09-13Clinical Trial Update: A Clinical Study to Evaluate Symbicort Turbuhaler Used 'as Needed' in Adults and Adolescents With Asthma. [Phase 3]
A Phase 3 clinical trial evaluated using Symbicort Turbuhaler as-needed in adults and adolescents with asthma; results have been posted afte…
-
CLINICAL_TRIALS research · 2019-09-13Clinical Trial Update: The Electronic Asthma Action Plan System for Implementation in Primary Care [NA]
A completed clinical trial evaluating an Electronic Asthma Action Plan System for use in primary care settings.
-
CLINICAL_TRIALS withdrawal · 2019-09-13Clinical Trial Update: Inhaled Corticosteroids on Airway Smooth Muscle in Asthma [Phase 4]
Phase 4 trial investigating inhaled corticosteroids on airway smooth muscle in asthma was withdrawn.
-
CLINICAL_TRIALS trial_result · 2019-09-12Clinical Trial Update: Study of QMF149 (150/80 µg) Compared With MF Twisthaler® (200 µg) in Patients With Asthma [Phase 3]
A Phase 3 trial comparing fixed-dose QMF149 (150/80 µg) to MF Twisthaler (200 µg) in patients with mild asthma; results have been posted aft…
-
CLINICAL_TRIALS trial_result · 2019-09-12Clinical Trial Update: Effects of Reducing Indoor Air Pollution on the Adult Asthmatic Response [NA]
A completed clinical trial investigated whether reducing indoor air pollution affects the adult asthmatic response.
-
CLINICAL_TRIALS trial_result · 2019-09-09Clinical Trial Update: Targeted Small Airways Therapy in Persistent Asthma [Phase 4]
Phase 4 clinical trial update for a targeted small airways therapy in persistent asthma has completed.
-
FDA approval · 2019-09-06FDA Approved: PULMICORT FLEXHALER — Supplemental Application (H2-Pharma LLC)
The FDA approved a supplemental application for Pulmicort Flexhaler (budesonide) submitted by H2-Pharma LLC.
-
CLINICAL_TRIALS trial_result · 2019-09-06Clinical Trial Update: AZMATICS: AZithroMycin/Asthma Trial In Community Settings [Phase 3]
A Phase 3 clinical trial update for AZMATICS (AZithroMycin) in asthma has completed with results posted.
-
FDA approval · 2019-09-06FDA Approved: ALBUTEROL SULFATE — Original Application (QUAGEN PHARMACEUTICALS LLC)
FDA approves QUAGEN PHARMACEUTICALS LLC's ALBUTEROL SULFATE original application, granting a generic albuterol sulfate product for relief of…
-
CLINICAL_TRIALS trial_result · 2019-09-06Clinical Trial Update: A Study to Evaluate the Safety of Tralokinumab in Adults and Adolescents With Uncontrolled Asthma [Phase 3]
Phase 3 trial evaluating safety of tralokinumab in adults and adolescents with uncontrolled asthma was terminated; results posted in 2019.
-
CLINICAL_TRIALS trial_result · 2019-08-28Clinical Trial Update: Bronchial Thermoplasty for Severe Asthmatics Guided by HXe MRI [Phase 2, Phase 3]
Phase 2/3 clinical trial updates investigational bronchial thermoplasty guided by hyperpolarized xenon MRI for severe asthma; study complete…
-
CLINICAL_TRIALS trial_result · 2019-08-21Clinical Trial Update: Effects of p38 Inhibitor AZD7624 in Corticosteroid Resistant Asthma [Phase 2]
Phase 2 trial update evaluating the p38 inhibitor AZD7624 in corticosteroid-resistant asthma has completed.
-
CLINICAL_TRIALS trial_result · 2019-08-20Clinical Trial Update: Clinical Trial of NAC in Asthma [Phase 4]
Phase 4 clinical trial of N-acetylcysteine (NAC) in asthma was terminated; results have been posted.
-
CLINICAL_TRIALS trial_result · 2019-08-13Clinical Trial Update: Response of the Airway in Sinusitis and Asthma [Phase 4]
Phase 4 clinical trial update evaluating airway response in sinusitis and asthma.
-
FDA approval · 2019-08-12FDA Approved: DULERA — Supplemental Application (Organon LLC)
FDA approved a supplemental application for DULERA (mometasone furoate/formoterol fumarate dihydrate) from Organon LLC.